Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis

Laura Villani; Vittorio Rosti; Margherita Massa; Rita Campanelli; Paolo Catarsi; Adriana Carolei; Carlotta Abbà; Annalisa De Silvestri; Robert Peter Gale; Giovanni Barosi

doi:10.1016/j.leukres.2021.106730

Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis

Laura Villani, Vittorio Rosti, Margherita Massa, Rita Campanelli, Paolo Catarsi, Adriana Carolei, Carlotta Abbà, Annalisa De Silvestri, Robert Peter Gale, Giovanni Barosi

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	106730
Journal	Leukemia Research
Volume	111
DOIs	https://doi.org/10.1016/j.leukres.2021.106730
Publication status	Published - Dec 2021

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2021.106730

Cite this

@article{7460b178739e4f88806eed407d9cdfd9,

title = "Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis",

author = "Laura Villani and Vittorio Rosti and Margherita Massa and Rita Campanelli and Paolo Catarsi and Adriana Carolei and Carlotta Abb{\`a} and {De Silvestri}, Annalisa and Gale, {Robert Peter} and Giovanni Barosi",

note = "Funding Information: Supported by AIRC 5 x 1000 call “Metastatic disease: the key unmet need in oncology” to MYNERVA project, #21267 (MYeloid Research Venture AIRC); by Ricerca Corrente IRCCS Policlinico San Matteo Foundation, Pavia, Italy , project number 874, code number 08054517, received by VR (Vittorio Rosti).",

year = "2021",

month = dec,

doi = "10.1016/j.leukres.2021.106730",

language = "English",

volume = "111",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Primary myelofibrosis

T2 - rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis

AU - Villani, Laura

AU - Rosti, Vittorio

AU - Massa, Margherita

AU - Campanelli, Rita

AU - Catarsi, Paolo

AU - Carolei, Adriana

AU - Abbà, Carlotta

AU - De Silvestri, Annalisa

AU - Gale, Robert Peter

AU - Barosi, Giovanni

N1 - Funding Information: Supported by AIRC 5 x 1000 call “Metastatic disease: the key unmet need in oncology” to MYNERVA project, #21267 (MYeloid Research Venture AIRC); by Ricerca Corrente IRCCS Policlinico San Matteo Foundation, Pavia, Italy , project number 874, code number 08054517, received by VR (Vittorio Rosti).

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85117703657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117703657&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2021.106730

DO - 10.1016/j.leukres.2021.106730

M3 - Letter

AN - SCOPUS:85117703657

VL - 111

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

M1 - 106730

ER -

Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this